Skip to main content
. 2024;25(9):3229–3237. doi: 10.31557/APJCP.2024.25.9.3229

Table 3.

Factors Predicting Event Free Survival (EFS) and Overall Survival (OS) (Cox Regression Analysis for the Entire Cohort).

Parameters N= 243 Median EFS
(months)
3-year EFS(%) EFS univariate
HR (95%CI)
EFS multivariate
HR (95%CI)
Median OS
(months)
3-year OS (%) OS univariate
HR (95%CI)
OS multivariate
HR (95%CI)
Age (years) 0-14 116 Not reached 61.8 Not reached 63.2
15-39 100 14.7(8.1-21.2) 36.4 2.19 (1.49-3.23) 2.01(1.30-3.09) 19 42 2.16(1.42-3.29) 1.9 (1.2-3.0)
40-70 27 10.3(0-27.2) 27 3.36 (1.59-5.68) 2.14(0.98-4.66) 10.3 33.7 2.60(1.44-4.68) 2.2(1-4.7)
1.22 (0.85-1.75)
Sex Male 157 22.9 49.2 26.4 50
Female 86 18.6(13.4-24) 43.9 19.7(12.1-28.6) 43.8 1.35(0.91-1.99)
1.59 (1.11-2.29)
ECOG 0-1 171 24.2 50.9 26.4 49.5
>2 72 15.1(6.6-23.6) 38.9 1.22(0.79-1.92) 17.7(10-30) 44 1.49(0.99-2.23) 1.1(0.7-1.8)
Diagnosis B-ALL 172 21 47.8 52.1 48.8
T-ALL 66 18.6(12.8-24.4) 46.9 1.24 (0.84-1.84) 21.1 45.9 1.135(0.71-1.81)
Negative 192 21 47.1 26.4 48
Ph+ALL Positive 25 10.3(6.5-19.4) 25.2 1.82 (1.07-3.09) 0.74(0.37-1.47) 12.9(6.4-19.4) 37.2 1.80(1-3.1)
TLC <50k 175 28.3 51 39.6 53.8
>50k 68 13.1(9.1-17.2) 30.3 1.71 (1.18-2.48) 1.51(0.99-2.31) 19.4(12.6-26.2) 26.4 2.105(1.35-3.26) 1.8(1.1-2.8)
Blasts 0-20% 64 Not reached 67.3 Not reached 72.7
21-50% 24 22.9 22 1.53(0.7-3.2) 24(17.6-30.4) 44.3 1.9(0.9-4.1)
>51 % 126 19.4(13-26) 19.4 2.0(1.2-3.4) 26.4(10.2-42.6) 44.1 2.2(1.2-3.9)
D8 Res PPR 216 22.9(0.1-47.7) 47.7 10.7 31
GPR 27 4.4(0-11.3) 25.9 2.36 (1.46-3.80) 2.70(1.58-4.63) 26.4 50 2.537(1.47-4.37) 2.3(1.3-4.1)
MRD Status of IA Negative 66 Not reached 65.6 Not reached 65.2
Positive 19 16.9 49.3 1.65 (0.75-3.65) Not reached 59.5 1.25(0.52-3.0)
Platelet partial recovery Early (D22) 130 56.2 62.2
Late (D23+) 77 17.7(13.7-21.6) 39.9 1.71(1.14-2.55) 1.63(1.07-2.47) 21.37(13-29) 44.1 1.74(1.13-2.67) 1.5 (1-2.4)

*Factors significant in univariate analysis were taken for multivariate regression.*Abbreviations- EFS, event free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; ECOG, Eastern Cooperative Oncology Group; TLC, total leucocyte count; MRD, minimal residual disease